Article

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection

2021-04-19

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic, causing health and economic problems. Currently, as dangerous mutations emerge there is an increased demand for specific treatments for SARS-CoV-2 infected patients. The spike glycoprotein on the virus membrane binds to the angiotensin converting enzyme 2 (ACE2) receptor on host cells through its receptor binding...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 137b135c-93a3-55a5-b32b-4ade8052f6c9
DOI: 10.1101/2021.04.18.440302

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infectionDOI 10.1101/2021.04.18.440302Read

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.Semantic proximity Read

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralizationSemantic proximity Read

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy.Semantic proximity Read

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and AntibodiesSemantic proximity Read

An Innovative antibody-based Plug-and-Play strategy for SARS-CoV-2Semantic proximity Read

Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptidesSemantic proximity Read

Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion proteinSemantic proximity Read

ACE2-based decoy receptors for SARS coronavirus 2.Semantic proximity Read

Structural perspective of the interactions of ACE2 and SARS CoV-2 Spike protein RBDSemantic proximity Read

Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion proteinSemantic proximity Read

ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2Semantic proximity Read

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesSemantic proximity Read